Latest Articles
Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference - BioSpace
Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference BioSpace
Published: Aug. 7, 2026, 12:17 p.m.
Whitehawk Therapeutics reports Q2 2026 net loss $16.6M; cash $190.0M funds into 2H 2028 - TradingView
Whitehawk Therapeutics reports Q2 2026 net loss $16.6M; cash $190.0M funds into 2H 2028 TradingView
Published: Aug. 6, 2026, 2:13 p.m.
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery - Business Wire
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery Business Wire
Published: Aug. 6, 2026, 10:30 a.m.
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery - businesswire.com
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery businesswire.com
Published: Aug. 6, 2026, 10:30 a.m.
Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates - BioSpace
Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates BioSpace
Published: Aug. 5, 2026, 4:22 a.m.
Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates - FinancialContent
Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates FinancialContent
Published: Aug. 4, 2026, 11:30 a.m.
Faeth Therapeutics Rebrands, Relocates and Overhauls Leadership - The Globe and Mail
Faeth Therapeutics Rebrands, Relocates and Overhauls Leadership The Globe and Mail
Published: June 16, 2026, 1:17 p.m.
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline - The Manila Times
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline The Manila Times
Published: June 11, 2026, 7:39 a.m.
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline - GlobeNewswire
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline GlobeNewswire
Published: June 11, 2026, 7:30 a.m.
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com UK
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com UK
Published: May 21, 2026, 8:34 p.m.
Link copied to clipboard!